Your search returned 47 studies. (Get alerts for new studies):
- A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas
Conditions: Mixed Gliomas - Malignant Gliomas - Glioblastoma Multiforme
1 Location available
- Delta-24-RGD for Recurrent Malignant Gliomas
Conditions: Brain Cancer - Central Nervous System Diseases
1 Location available
- A Study in Subjects With Recurrent Malignant Glioma
Conditions: Glioma
3 Locations available
- Dose-Intensive Chemotherapy in Combination With Chemoprotected Autologous Stem Cells for Patients With Malignant Gliomas
Conditions: Adult Giant Cell Glioblastoma - Adult Glioblastoma - Adult Gliosarcoma
1 Location available
- Phase I Dose Escalation Study of Vandetanib w/ Hypofractionated Stereotactic Radiotherapy in Patients w/ Recurrent Malignant Gliomas
Conditions: Malignant Gliomas
1 Location available
- LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma
Conditions: Malignant Glioma
4 Locations available
- Intravenous Palonosetron With Radiotherapy and Concomitant Temozolomide
Conditions: Malignant Glioma
1 Location available
- AMG 102 and Avastin for Recurrent Malignant Glioma
Conditions: Grade IV Malignant Glioma - Glioblastoma Multiforme - Gliosarcoma
1 Location available
- Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas
Conditions: Glioma
1 Location available
- A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors
Conditions: Malignant Glioma - Glioma - Glioblastoma - Glioblastoma Multiforme - Astrocytoma
1 Location available
- Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
Conditions: Brain Cancer - MALIGNANT GLIOMA - Glioblastoma - Anaplastic Astrocytoma (AA) - Anaplastic Oligodendroglioma (AO) - Anaplastic Oligo-astrocytoma (AOA) - Anaplastic Mixed Gliomas - Malignant Glioma NOS
3 Locations available
- A Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain
Conditions: Glioma
1 Location available
- Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Ph2 PF-00299804 in Relapsed/Recurrent GBM
Conditions: Malignant Glioma
1 Location available
- RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
Conditions: Brain and Central Nervous System Tumors
2 Locations available
- EGFR Inhibition Using High Dose Administration of Erlotinib Weekly for Recurrent Malignant Gliomas With EGFR Variant III Mutation
Conditions: Brain Cancer
3 Locations available
- Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma
Conditions: Glioma
1 Location available
- Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Trial of Enzastaurin and Bevacizumab in Adults With Recurrent Malignant Gliomas
Conditions: Recurrent Glioblastoma
1 Location available
- Aloxi for Prevention of Acute and Delayed Chemotherapy Induced Nausea and Vomiting (CINV) in Malignant Glioma (MG) Patients Receiving Irinotecan With
Conditions: Brain Cancer
1 Location available
- Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme
Conditions: Malignant Gliomas
1 Location available
- A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas
Conditions: Malignant Glioma
4 Locations available
- Sunitinib to Treat Recurrent Brain Cancer
Conditions: Glioblastoma Multiforme - Malignant Gliomas - Anaplastic Gliomas
1 Location available
- Natural History Study of Patients With Neurofibromatosis Type I
Conditions: Neurofibromatosis Type 1 - Malignant Peripheral Nerve Sheath Tumor - Plexiform Neurofibroma - Optic Glioma - Neurofibroma
1 Location available
- AZD7451 for Recurrent Gliomas
Conditions: Glioblastoma Multiforme - Gliosarcoma - Anaplastic Astrocyloma - Oligoastrocytoma - Malignant Glioma
1 Location available
- Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery
Conditions: Brain and Central Nervous System Tumors
3 Locations available
- Valproic Acid and Radiation Followed by Maintenance Valproic Acid and Bevacizumab in Children With High Grade Gliomas
Conditions: Glial Cell Tumors - Malignant Gliomas
5 Locations available
- Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma
Conditions: Adult Anaplastic Astrocytoma - Adult Anaplastic Oligodendroglioma - Adult Diffuse Astrocytoma - Adult Giant Cell Glioblastoma - Adult Glioblastoma - Adult Gliosarcoma - Adult Mixed Glioma - Adult Oligodendroglioma - Recurrent Adult Brain Tumor
1 Location available
- A Study of a Retroviral Replicating Vector Administered to Subjects With Recurrent Malignant Glioma
Conditions: Glioblastoma - Anaplastic Astrocytoma - Anaplastic Oligodendroglioma - Anaplastic Oligoastrocytoma
4 Locations available
- Bevacizumab Plus Irinotecan Plus Carboplatin for Recurrent Malignant Glioma (MG)
Conditions: Malignant Glioma
1 Location available
- Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytol
Conditions: Anaplastic Astrocytoma - Anaplastic Ependymoma - Anaplastic Meningioma - Anaplastic Oligodendroglioma - Brain Stem Glioma - Ependymoblastoma - Giant Cell Glioblastoma - Glioblastoma - Gliosarcoma - Grade III Meningioma - Meningeal Hemangiopericytoma - Mix
1 Location available
- Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Conditions: Glioblastoma Multiforme - Anaplastic Astrocytoma - Anaplastic Oligodendroglioma - Anaplastic Oligoastrocytoma
3 Locations available
- Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma
Conditions: Glioblastoma
8 Locations available
- Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant
Conditions: Solid Tumors - Glioblastoma Multiforme - Recurrent Malignant Gliomas
2 Locations available
- Safety Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Tumors of the Brain
Conditions: Glioma
1 Location available
- Low-Dose Naltrexone for Glioma Patients
Conditions: Malignant Glioma
1 Location available
- AZD8055 for Adults With Recurrent Gliomas
Conditions: Glioblastoma Multiforme - Anaplastic Astrocytoma - Anaplastic Oligodendroglioma - Malignant Glioma - Brainstem Glioma
1 Location available
- Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma
Conditions: Extra-adrenal Paraganglioma - Paraganglioma - Pheochromocytoma
7 Locations available
- Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma
Conditions: Brain and Central Nervous System Tumors
42 Locations available
- MRI-Guided Laser Induced Thermal Therapy
Conditions: Malignant Glioma
1 Location available
- Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
Conditions: Glioblastoma - Gliosarcoma - Anaplastic Astrocytoma - Anaplastic Oligodendroglioma - Anaplastic Mixed Oligoastrocytoma - Malignant Astrocytoma NOS
1 Location available
- Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant High Grade Gliomas and to Design Potential Radiation Plans
Conditions: Brain Cancer - Glioma
1 Location available
- Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
Conditions: Glioma
3 Locations available
- Nuvigil or Placebo in Newly Diagnosed Malignant Glioma
Conditions: Malignant Glioma
1 Location available
- White Blood Cells With Anti-EGFR-III for Malignant Gliomas
Conditions: Malignant Glioma - Glioblastoma - Brain Cancer
1 Location available
|